NetScientific has exited its loss-making portfolio companies Vortex and Wanda after originally deciding to close the two medical diagnostics ventures last week.

Commercialisation firm NetScientific sold its majority stakes in US-based medical diagnostics portfolio companies Vortex Biosciences and Wanda on Friday to investment firm EMV Capital for £150,000 ($199,000). NetScientific had opted to close the two businesses through an orderly wind-down last week as it had concluded an earlier EMV Capital approach was insufficient to cover the…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.